Cargando…
Response to Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth”
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119509/ https://www.ncbi.nlm.nih.gov/pubmed/33565040 http://dx.doi.org/10.1007/s40122-020-00224-x |
| _version_ | 1783691871755698176 |
|---|---|
| author | McAnally, Heath B. Bonnet, Udo |
| author_facet | McAnally, Heath B. Bonnet, Udo |
| author_sort | McAnally, Heath B. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8119509 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81195092021-05-14 Response to Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth” McAnally, Heath B. Bonnet, Udo Pain Ther Letter Springer Healthcare 2021-02-09 2021-06 /pmc/articles/PMC8119509/ /pubmed/33565040 http://dx.doi.org/10.1007/s40122-020-00224-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Letter McAnally, Heath B. Bonnet, Udo Response to Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth” |
| title | Response to Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth” |
| title_full | Response to Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth” |
| title_fullStr | Response to Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth” |
| title_full_unstemmed | Response to Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth” |
| title_short | Response to Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth” |
| title_sort | response to comment on “gabapentinoid benefit and risk stratification: mechanisms over myth” |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119509/ https://www.ncbi.nlm.nih.gov/pubmed/33565040 http://dx.doi.org/10.1007/s40122-020-00224-x |
| work_keys_str_mv | AT mcanallyheathb responsetocommentongabapentinoidbenefitandriskstratificationmechanismsovermyth AT bonnetudo responsetocommentongabapentinoidbenefitandriskstratificationmechanismsovermyth |